Neoadjuvant chemotherapy for pineal region tumors - Takeaways - MDSpire

Neoadjuvant chemotherapy for pineal region tumors

  • By

  • Christopher Troy

  • David G. Laird

  • Cameron Brimley

  • Soniya Pinto

  • Sean Himel

  • Carlos Osorno-Cruz

  • Mustafa Motiwala

  • Emal Lesha

  • Kelly Chamberlin

  • Giles Robinson

  • Amar Gajjar

  • Jason Chiang

  • Nir Shimony

  • David S. Hersh

  • Paul Klimo

  • June 3, 2026

  • 0 min

Share

  • 1

    Pineal region tumors account for 3–11% of pediatric brain tumors, primarily affecting children with obstructive hydrocephalus symptoms.

  • 2

    Neoadjuvant chemotherapy can reduce tumor vascularity and volume, improving surgical resection safety and feasibility for pineal tumors.

  • 3

    The study focused on children and young adults undergoing resection of pineal tumors after at least two rounds of neoadjuvant chemotherapy.

  • 4

    Multidisciplinary treatment strategies are essential due to the histologic diversity and complex management of pineal region tumors.

  • 5

    Preoperative imaging and tumor marker analysis are crucial for guiding treatment decisions and assessing the need for neoadjuvant chemotherapy.

Original Source(s)

Neoadjuvant chemotherapy for pineal region tumors

  • by Christopher Troy, David G. Laird, Cameron Brimley, Soniya Pinto, Sean Himel, Carlos Osorno-Cruz, Mustafa Motiwala, Emal Lesha, Kelly Chamberlin, Giles Robinson, Amar Gajjar, Jason Chiang, Nir Shimony, David S. Hersh, Paul Klimo

  • June 3, 2026

Related Content

A screening model for advanced colorectal neoplasia based on tumor markers and inflammatory indices: a retrospective study with an online risk calculator

Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis

Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials: A Systematic